"10.1371_journal.pone.0014831","plos one","2011-09-07T00:00:00Z","Sara J Whitehead; Catherine McLean; Supaporn Chaikummao; Sarah Braunstein; Wat Utaivoravit; Janneke H van de Wijgert; Philip A Mock; Taweesap Siraprapasiri; Barbara A Friedland; Peter H Kilmarx; Lauri E Markowitz","Thailand Ministry of Public Health–U.S. Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America; Population Council, New York, New York, United States of America; Chiang Rai Hospital, Chiang Rai, Thailand; Academic Medical Center of the University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands","Conceived and designed the experiments: JvdW CAM BF PHK LEM. Performed the experiments: CAM SC. Analyzed the data: SJW PAM.  Wrote the manuscript: SJW. Contributed to study monitoring and implementation: JvdW. Supervised field staff: SJW SC. Developed Standard Operating Procedures, monitored trial conduct, contributed to analysis of acceptability data: SB. Coordinated field site support and referral: WU.  Coordinated field staff supervision and implementation: TS. Supported implementation of the study: BF. Supervised implementation of the study: PHK LEM.","None of the authors have a commercial association with Carraguard or other conflicts of interest. Carraguard® is being developed by the Population Council, which is a not-for-profit nongovernmental organization, under a U.S. Food and Drug Administration Investigational New Drug Application (IND 58,441).","2011","09","Sara J Whitehead","SJW",11,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
